IBN Sina Pharma recommends 38.5% cash dividend
The dividend payout was recommended at the company’s board meeting on Thursday afternoon
Publicly listed company, IBN Sina Pharmaceutical Industry Ltd, has recommended a 38.5% cash dividend to its shareholders for the year that ended on June 30, 2020.
The dividend payout was recommended at the company's board meeting on Thursday afternoon.
The approval of the dividend will be finalised at an annual general meeting (AGM) slated for November 12, 2020 in Dhaka. The record date is set for October 12.
Keep updated, follow The Business Standard's Google news channel
According to the price-sensitive information released by the company, it reported a consolidated earnings per share (EPS) of Tk12.43 as of June 2020, which was Tk10.76 in the previous financial year.
The company's EPS increased by 15.52% compared to that in the previous year.
Besides, the consolidated net asset value (NAV) per share stood at Tk56.74 for the year that ended on June 30, 2020.
The company paid a 30% cash dividend to its shareholders for the 2018-19 financial year. Currently, its paid-up capital is Tk31.44 crore.
Sponsors and directors jointly own 44.44% shares of the company, institutional investors 21.26% and general investors own 34.3% shares.
The closing price of each share of the company was Tk252.30 on Thursday at the Dhaka Stock Exchange. The company's shares hit their highest price of Tk280 per share within the last one year.
IBN Sina Pharmaceutical Industry Ltd started its journey in 1983.
The company produces pharmaceutical drugs and natural medicines and sells them in both the local and international markets.
